hypoparathyroidism inadequate secretion of parathyroid hormone
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Patients who are aged 18 years or older at the time of inclusion - Patients who gave informed consent - Both cases and controls underwent (completion) thyroidectomy - Cases have persisting hypoparathyroidism according to the previously mentioned definition and controls do not
Exclusion criteria
Exclusion criteria: - Patients who are not able to provide written informed consent - No adequate understanding of the Dutch language - Parathyroid disease or parathyroid surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main study endpoints are quality of life in patients with hypoparathyroidism as measured by the physical component score of the SF-36. Other endpoints are cognitive and functional outcomes and burden of disease (eg. extra visits, employment status, comorbidities). | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary objectives of this study are: - To determine the Thyroid-Related quality of life in patients with hypoparathyrodism - To determine the cognitive and functional outcomes in patients with hypoparathyrodism - To determine the burden of disease in patients with hypoparathyroidism (eg. Medication use, the absence of work/return to work, extra hospital visits, comorbidities, hypoparathyroidism related laboratory parameters) | — |
Countries
Netherlands